Delivery Order SPE2DB22D3016-SPE2DB25FAQA4
Award Date
3/3/25
Potential Completion Date
3/4/25
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,306.08, is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits, a specialty medication used in the treatment of certain medical conditions. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 5, 2025. This award is not associated with a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Neulasta OnPro 6 mg/0.6 ml kits. The delivery order, valued at $7,092.23, is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a $2,465.76 firm-fixed price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Neulasta OnPro 6 mg/0.6 ml kits. The order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's global military treatment programs and...
This federal contract award, valued at $25,759.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the delivery of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of the pharmaceutical product Neulasta 6 mg/0.6 mL syringe to the Defense Logistics Agency (DLA). The contract, valued at $2,038.95, was awarded to the prime contractor Amerisourcebergen Drug Corp, which is the corporate office division of the larger Amerisourcebergen Corporation. The contract is a delivery order under an existing Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to...
This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $1,214.78, for the supply of NEUPOGEN 300 MCG/ML VIALML. This medical product is likely used to support military healthcare programs. The contract has a period of performance through February...
This federal contract award is for the pharmaceutical product Neupogen 480 mcg/0.8 mL syringe, awarded to the prime contractor Amerisourcebergen Drug Corp. The $2,482.88 firm fixed price delivery order has an ultimate completion date of November 22, 2024. The contract was awarded on November 21, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency supplying medical products to military treatment facilities and veterans' healthcare programs. Amerisourcebergen, a...
This federal contract award is for the delivery of NEUPOGEN 480 MCG/1.6 ML VIAL 1.6ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $19,111.26, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,932.26, is a delivery order for the supply of GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that...